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ABSTRACT: Lin28A is a post-transcriptional regulator of
gene expression that interacts with and negatively regulates the
biogenesis of let-7 family miRNAs. Recent data suggested that
Lin28A also binds the putative tumor suppressor miR-363, a
member of the 106~363 cluster of miRNAs. Affinity for this
miRNA and the stoichiometry of the protein−RNA complex
are unknown. Characterization of human Lin28’s interaction
with RNA has been complicated by difficulties in producing
stable RNA-free protein. We have engineered a maltose binding
protein fusion with Lin28, which binds let-7 miRNA with a Kd
of 54.1 ± 4.2 nM, in agreement with previous data on a murine homologue. We show that human Lin28A binds miR-363 with a
1:1 stoichiometry and with a similar, if not higher, affinity (Kd = 16.6 ± 1.9 nM). Further analysis suggests that the interaction of
the N-terminal cold shock domain of Lin28A with RNA is salt-dependent, supporting a model in which the cold shock domain
allows the protein to sample RNA substrates through transient electrostatic interactions.
Lin28 proteins are key post-transcriptional regulators ofgene expression in higher eukaryotes.1 They comprise two
RNA binding domains: an N-terminal cold shock domain
(CSD) and a C-terminal zinc knuckle (ZnK) domain with two
tandem CCHC-type zinc knuckles. This unique domain
combination allows specific interactions with mRNAs and
microRNAs (miRNAs) that contain conserved GGAG/GGUG
motifs.1−6 Because of these interactions, Lin28 has been
implicated in pluripotency,7−9 development,10−13 alternative
splicing,4 metabolism,12,14 and cancer.15−17 Identifying Lin28
targets and characterizing their interactions with Lin28 are
therefore critical for understanding the molecular basis of
Lin28-associated disorders.
The inhibition of let-7 family miRNA biogenesis by Lin28
has been widely studied. The binding of Lin28 to pre-let-7 in
the cytoplasm prevents access of Dicer to its cleavage site.
Further recruitment of terminal uridylyl transferase Zcchc11
results in the addition of a 3′ poly(U) tail,6,18 targeting the
precursor RNA for degradation by the Dis3L2 nuclease.19 A
crystal structure of murine Lin28a in complex with let-7 RNA
showed that the CSD binds the loop/pre-element/preE region
of the miRNA while the ZnK domain contacts the GGAG motif
(illustrated in Figure 1A).20 Analysis of Xenopus Lin28b showed
that the protein bound 83-nucleotide Xenopus-pre-let-7f RNA
with a Kd of 1.6 μM.
21 The same study showed that CSD
remodels RNA structure to facilitate binding of the ZnK
domain to the GGAG motif. More recent work with murine
Lin28a suggested that the remodeling of RNA serves to expose
additional sites for Lin28 binding, giving rise to 2:1 and 3:1
protein−RNA complexes, where effectively the protein shields
pre-let-7 from Dicer.22 An overall affinity of 0.13 nM was
reported for such binding of Lin28 to a 46-nucleotide let-7g
substrate.23 Affinities of 1.7 and 0.29 nM were observed for 14-
nucleotide GAGG- and GGAG-containing segments of this
substrate, respectively.22
Among miRNAs outside of the let-7 family, several contain a
3′-GGAG motif and are targets of Lin28-dependent uridylation
by Zcchc11.6 In contrast, miR-363 of the 106~363 cluster,
which also has this motif (Figure 1B) and a binding partner of
Lin28, is not subjected to uridylation by Zcchc11, suggesting
that its interaction with Lin28 is part of a previously
uncharacterized regulatory pathway. Recently, a direct inter-
action between Xenopus Lin28 and the terminal loop of the
precursor Xenopus-miR-363 has been described.24 Contrary to
what was observed for let-7 RNAs, knockdown of Lin28 in
morphant embryos led to a decrease in mature miR-363 levels,
suggesting an alternate function for Lin28 as a positive
regulator of miR-363.
Previous studies of the interaction of human Lin28 with
RNA were undermined by the unstable nature of this protein in
the absence of bound nucleic acid. Here, we report a new
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strategy for producing stable, RNA-free, recombinant human
Lin28. We show that the human protein binds both let-7g and
miR-363 with high affinity in a 1:1 stoichiometry. We further
show that this complex is resistant to changes in ionic strength.
In contrast, the CSD on its own binds in a manner that is
highly dependent on ionic strength. These data suggest that the
electrostatic properties of CSD play a major role in helping
Lin28 search for RNA targets in the transcriptome.
■ EXPERIMENTAL PROCEDURES
Protein Production. The plasmid encoding the His-MBP-
Lin28TT fusion protein (Figure 1C) was produced from the
pETFF_2 plasmid provided by the York Technology Facility.
The sequence encoding residues 32−187 of human Lin28A
(NCBI accession number NP_078950.1) was amplified by
polymerase chain reaction (PCR) from a synthetic, codon-
optimized template (GeneArt). The pETFF_2 vector was
linearized by PCR and purified by agarose gel electrophoresis.
The Lin28 sequence was then inserted into the pETFF_2
vector using the In-Fusion ligation system (Clontech) and the
product transformed into Escherichia coli.
The plasmid encoding the His-MBP-Lin28TT protein was
transformed into the Rosetta2 (DE3) E. coli expression strain.
Cells were grown in LB medium supplemented with 50 μM
ZnCl2 to an OD600 of 0.6. Expression was then induced by the
addition of 1 mM isopropyl β-D-1-thiogalactopyranoside, and
cells were grown overnight at 16 °C. Cells were harvested,
resuspended on ice in 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 2 mM β-mercaptoethanol, 10 μM ZnCl2, and 20 mM
imidazole, and lysed by sonication. The lysate was applied to a
Zn2+-charged 5 mL HisTrap column (GE Healthcare) at 4 °C.
The column was then washed for 16 h (flow rate of 0.1 mL/
min) at 4 °C, with a solution containing 50 mM MES (pH 6.0),
1 M NaCl, 2 mM β-mercaptoethanol, 10 μM ZnCl2, and 20
mM imidazole to remove nucleic acid contaminants. Bound
proteins were eluted using 50 mM MES (pH 6.0), 1 M NaCl, 2
mM β-mercaptoethanol, 10 μM ZnCl2, and 500 mM imidazole.
The eluted protein was applied to a S200 10/300 gel filtration
column (GE Healthcare) in a solution containing 10 mM MES
(pH 6.0), 1 M NaCl, 2 mM β-mercaptoethanol, and 10 μM
ZnCl2. Fractions containing the Lin28 fusion protein were
concentrated and dialyzed against a solution containing 10 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM β-mercaptoethanol,
and 10 μM ZnCl2 before being flash-frozen in liquid nitrogen
for storage.
RNA Constructs. Unlabeled and 5′-fluorescein-labeled
RNA corresponding to human let-7g and miR-363 (Figure
1D,E) were synthesized by Dharmacon. A cytosine was
introduced to the 5′ end of the let-7g RNA for additional
stability from base pairing. A similar approach was taken in
previous studies of murine let-7g RNA.20
SEC−MALLS. A Biosep SEC S3000 column (Phenomenex)
was pre-equilibrated with 20 mM Tris (pH 7.5) and 250 mM
NaCl buffer and connected to a Dawn Helios II 18-angle light-
scattering detector (Wyatt Technology). Lin28 fusion protein
samples were diluted to 2 mg/mL (34 and 38 μM for His-
MBP-Lin28TT and His-MBP-CSD, respectively) in buffer or
buffer with equimolar amounts of RNA oligonucleotide. The
eluting species were detected by measuring the UV absorbance
at 280 nm; the concentration of the species was determined
using an Optilab rEX refractometer (Wyatt Technology), and a
refractive index increment of 0.185 mL/g was used for
calculation of the molecular weight in the ASTRA V software.
Figure 1. Lin28 and miRNA. (A) Architecture of the complex of Lin28 with miRNA.20 (B) Alignment of pre-miR-363 sequences from several
vertebrates. The conserved GGAG motif is highlighted (red box), and the region of the sequence corresponding to the miR-36319−46 segment used
in this study is colored orange; segments of full-length mature miR-363 are colored blue (5′) and green (3′). (C) Schematic of Lin28 constructs used
in this study. Secondary structures of (D) let-7g29−57 and (E) miR-36319−46, predicted by MFOLD.27
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Weight-average molecular weight values and the associated
error of the fit are reported.
Fluorescence Anisotropy. Titrations were performed
using increasing concentrations of protein and 20 nM 5′-
fluorescein-labeled RNA in 200 μL final volumes, in triplicate.
The sample buffer contained 20 mM Tris-HCl (pH 7.5), 50−
750 mM NaCl, 10 mM β-mercaptoethanol, 50 μM ZnCl2, and
0.01% (v/v) Tween 20. Fluorescence readings were taken in a
black flat-bottom 96-well plate (Nunc) at 25 °C in a BMG
POLARstar Optima plate reader with the detector gain set
using an initial measurement of 20 nM free fluorescein in
buffer. Dissociation constants for His-MBP-Lin28TT−RNA
interactions were determined by fitting the following equation
in Prism (GraphPad):
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×
+ + − + + −
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where x is the concentration of protein in nanomolar, y is the
anisotropy (×1000), Amin is the anisotropy of free labeled RNA,
Amax is the maximal anisotropy, c is the total concentration of
labeled RNA (set to 20 nM), and Kd is the dissociation
constant.
■ RESULTS
Human Lin28 Fused to MBP Can Be Purified as a
Soluble, Nucleic Acid-Free Preparation. Initial attempts to
produce nucleic acid-free human Lin28A as a His6 fusion failed,
as the protein quickly became lost upon removal of the nucleic
acid with NaCl treatment (Figure S1). To improve solubility
and stability, constructs were designed in which Lin28A
(residues 32−187, Lin28TT) or the CSD on its own (residues
32−127) was fused with His-tagged maltose binding protein
(His-MBP) via a three-alanine peptide linker (Figure 1C). A
long salt wash was included in the purification protocol to
remove nucleic acid contaminants, which otherwise caused all
protein to elute as a high-molecular weight protein/nucleic acid
mixture during size exclusion chromatography (Figure S2).
Human Lin28 Forms 1:1 Complexes with let-7g and
miR-363. The His-MBP-Lin28TT fusion protein eluted in two
steps during size exclusion chromatography: a sharp peak at 9.8
mL, corresponding to monomeric protein, with a weight-
average molecular weight of 65 ± 4 kDa, determined by
MALLS (theoretical mass of 59.5 kDa), and a broad peak in the
void volume, indicating aggregation and accounting for ∼24%
of the eluting protein mass, calculated on the basis of refractive
index measurements.
Injecting equimolar amounts of His-MBP-Lin28TT and let-
7g29−57 RNA resulted in an earlier eluting peak relative to free
monomeric protein and RNA (Figure 2A). An average
molecular weight of 72 ± 1 kDa was determined, comparable
to the theoretical mass of 68.4 kDa for a 1:1 protein−RNA
complex.
The interaction of Lin28 with miR-363 was investigated
using a 28-nucleotide RNA segment, which includes the
Figure 2. Analysis of the interaction of Lin28 with RNA. SEC−MALLS analysis of protein, RNA, and the protein−RNA complex with elution
profiles shown for (A) let-7g29−57 and (B) miR-36319−46. Fluorescence anisotropy analysis of the interaction of Lin28 with 5′-fluorescein-labeled (C)
let-7g29−57 and (D) miR-36319−46 in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 10 mM β-mercaptoethanol, 50 μM ZnCl2, and 0.01% (v/v) Tween
20.
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characteristic stem loop and the conserved GGAG motif [miR-
36319−46 (Figure 1A,E)]. As with let-7g, an earlier eluting peak
was observed for the protein/RNA mixture relative to free
monomeric protein and RNA, with an observed molecular
weight of 73 ± 2 kDa (Figure 2B). This agrees with the 68.8
kDa mass calculated for a 1:1 protein−RNA complex.
Lin28 Binds let-7g and miR-363 with High Affinity.
The affinities of human Lin28 for let-7 RNA and miR-363 were
subsequently measured. The fusion protein was titrated against
a constant concentration of 5′-fluorescein-labeled let-7g29−57
and miR-36319−46, and changes in fluorescence anisotropy were
measured (Figure 2C,D). Equilibrium dissociation constants of
54.1 ± 4.2 and 16.6 ± 1.9 nM were deduced, respectively,
under a 1:1 interaction model. No interaction was observed
between the His-MBP tag and RNA (Figure S3). These data
suggest that Lin28 binds let-7 RNA and miR-363 with
comparable affinities.
Lin28 CSD Forms Higher-Order Species with let-7g
and miR-363 RNA. To elucidate the role of the CSD in RNA
binding, a His-MBP-CSD fusion protein was produced and its
interactions with let-7g29−57 and miR-36319−46 were studied. A
significant peak in the void volume during size exclusion
chromatography indicated that His-MBP-CSD has a strong
tendency to aggregate, with approximately 76% of the eluting
protein present in this peak (Figure 3). A peak corresponding
to the 52 kDa monomeric protein could still be observed, with
an experimental molecular weight of 52 ± 1 kDa. When the
complex was mixed with let-7g and miR-363, a new peak
corresponding to the complex was observed with average
molecular weights of 76 ± 1 and 72 ± 2 kDa, respectively
(Figure 3). These values are between the expected molecular
weights of 62 and 113 kDa for 1:1 and 2:1 protein−RNA
complexes, respectively. These data could be the result of
protein aggregating while it is bound to RNA. Alternatively,
they may indicate that the CSD does not bind RNA in a strict
1:1 manner, in agreement with previous reports on murine
Lin28 forming high-order complexes with RNA.22 In contrast
with the relatively monodisperse 1:1 binding behavior exhibited
by the full-length protein, it can be proposed that the ZnK
domain facilitates the formation of stable 1:1 complexes.
Lin28−miR363 Complexes Are Insensitive to Salt
Concentration. To determine if electrostatic forces play any
role in the Lin28−miR-36319−46 interaction, the fluorescence
anisotropy experiments were repeated under different ionic
strength conditions. As the exact nature of the His-MBP-CSD−
RNA complexes is not known, an appropriate model for data
fitting could not be determined. However, the general trend in
the affinity of the interaction can be seen qualitatively by
comparing the anisotropy at different ionic strengths. The data
show that for the two-domain His-MBP-Lin28TT protein, the
affinity of the interaction remained relatively constant under all
conditions (Figure 4A and Table S1). Conversely, the His-
MBP-CSD−miR-36319−46 interaction became weaker as the
ionic strength of the buffer increased (Figure 4B), so much so
that no binding was observed at 750 mM NaCl. These data
show that unlike the case for the two-domain protein, the
interaction of the CSD with RNA is sensitive to ionic strength.
This implies that electrostatic interactions have a far greater
role when the ZnK domain is not present.
■ DISCUSSION
Lin28 Interacts with miR-363. The miR-363 miRNA was
identified as a potential binding partner of Lin28, as the 3′-
GGAG motif present in this sequence is highly conserved in
land-based vertebrates. miR-363 is a member of the 106~363
miRNA cluster, a cluster paralogous to the 17−92 miRNA
oncomir cluster.28,29 Recent reports have identified miR-363 as
a putative tumor suppressor. In neuroblastoma cells, miR-363
expression inhibits colony formation, growth, invasion, and
metastasis through downregulation of the MYO1D and
ADAM15 oncogenes.30 miR-363 expression has been also
linked with better prognosis and decreased metastatic potential
in head and neck squamous cell carcinoma due to its targeting
of podoplanin.31 Expression of miR-363 also inhibits the
growth of a cell line derived from a NK-cell lymphoma.32 Given
that both Lin28 and miR-363 are both implicated in the
development of cancer, understanding the nature of Lin28−
miR-363 interaction is of potential medical interest.
Previously reported Kd values for the interaction between
Lin28 proteins and let-7 RNAs20−23,25,26 display a large degree
of variation, with differences of >4 orders of magnitude. The
reasons for such a large discrepancy are likely complex and
could range from sample preparation to buffer conditions to the
length and structure of the oligonucleotide tested.
Here, we show that the miR-363 RNA segment containing
the characteristic stem loop followed by the GGAG motif forms
a relatively stable complex with a human Lin28A fusion protein,
Figure 3. SEC−MALLS analysis of the interaction of His-MBP-CSD
with RNA. Elution profiles are shown for protein, RNA, and protein−
RNA complexes for (A) let-7g29−57 and (B) miR-36319−46.
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with a Kd of 16.6 ± 1.9 nM under the described conditions
(Figure 2D). SEC−MALLS analysis indicates a 1:1 protein:R-
NA stoichiometry in the complex (Figure 2B). We also observe
a 1:1 interaction with an equivalent segment of let-7g RNA
(Figure 2A), in agreement with an earlier observation of a 1:1
complex made with an RNA oligonucleotide of similar length
and secondary structure, derived from the terminal loop of
Mmulet-7d.20 Additionally, the Kd of 54.1 ± 4.2 nM of this
interaction is comparable to the affinity of His-MBP-Lin28TT
for the miR-363 RNA segment (Figure 2D). The data therefore
indicate that Lin28 binds miR-363 and let-7 miRNAs in a
similar manner.
This finding is of interest as the Lin28−miR-363 complex
was shown to promote very little uridylation by Zcchc11
compared to that by let-7a-1.6 In addition, the evidence of a
direct interaction between amphibian Lin28 and miR-363, as
well as the observation that knockdown of Lin28 results in
decreased mature miR-363 levels, implies the alternative
function of Lin28 as a positive regulator of miRNA bio-
genesis.24 The results presented here show the similarities
between the binding modes of let-7g and miR-363. Previously,
it has been proposed that a change in the conformation of the
3′ terminus of the let-7g hairpin caused by Lin28 binding may
facilitate the recruitment of the TUTase responsible for let-7g
uridylation.20 Differences in the conformations of bound miR-
363 and let-7g would not be detectable by the methods
employed here but could account for the differences in the
biological outcomes of Lin28 binding through the recruitment
of different downstream effectors. Further studies identifying
factors that may interact with and influence binding of Lin28 to
miRNA, as well as structural information about such assemblies,
may be useful for improving our understanding of this system.
Determinants of Lin28:RNA Stoichiometry. A recent
study demonstrated that Lin28 binds the let-7g 46-nucleotide
stem loop segment in a stepwise manner, with up to three
protein molecules per RNA.22 Interactions were mediated by
three RNA segments, containing an exposed loop of the let-7g
stem loop or either the 5′-GGAG-3′ motif or its reverse (5′-
GAGG-3′). The let-7g29−57 oligonucleotide used here is shorter
(29 nucleotides) and contains only the 3′-GGAG motif.
Likewise, the miR-36319−46 and Mmu-let-7d RNA oligonucleo-
tides contain only one GGAG motif, at the 3′ end. It is
therefore possible that the stoichiometry of a Lin28−RNA
complex is determined by (1) the number of GGAG motifs
present in the RNA, which determine the specific attachment to
RNA, and (2) the length of the RNA, which determines the
number of CSD molecules that can be accommodated on
exposed single-stranded RNA regions.
Lin28 CSD Guides RNA Binding via Electrostatic
Attraction. The structures of murine Lin28A in complex
with let-7 family miRNA sequences,20 and of the Xenopus
Lin28B CSD domain,21 show binding of the CSD to single-
stranded oligonucleotides through stacking interactions be-
tween the RNA bases and aromatic side chains on the CSD
surface. In tandem, the ZnK domain binds the GGAG motif
through a hydrogen-bonding network, with a stacking
interaction formed between the side chain of Y140 and the
bases of the final A and G of the motif.20
The sensitivity of the interaction of His-MBP-CSD with
RNA to ionic strength (Figure 4B) implies that electrostatic
forces play an equally important role in RNA binding.
Examination of the CSD’s electrostatic surface reveals clear
areas of positive charge surrounding the nucleic acid binding
Figure 4. Effect of ionic strength on the interaction of Lin28 with miR-
363. Fluorescence anisotropy experiments were conducted using
fluorescein-labeled miR-36319−46 at different ionic strengths with
increasing concentrations of (A) His-MBP-Lin28TT or (B) His-MBP-
CSD. (C) Model of the complex of human CSD with nucleic acid
based on atomic structures of human Lin28b CSD (Protein Data Bank
entry 4A4I) and the Xenopus Lin28b CSD−DNA complex (Protein
Data Bank entry 4A75). The electrostatic surface potential for the
human CSD, from −1 V (red) to +1 V (blue).
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site (Figure 4C). Apart from Lys95 (Lys92 in the human CSD),
the phosphate groups seen in the structure are not directly
contacted by these areas of positive charge. However, a major
difference between the bacterial cold shock protein homologues
and the Lin28 CSD is the addition of two extra lysine residues
to strand β4, which results in a more basic binding platform.21
It is therefore possible that these areas of positive charge could
fulfill a key role in attracting and guiding RNA to the binding
site, facilitating the formation of base-specific hydrophobic and
hydrogen-bond interactions as observed in crystal structures.
In conclusion, we propose that Lin28 uses its CSD to sample
the transcriptome through transient electrostatic associations,
similar to how DNA binding proteins locate their target sites
through facilitated diffusion, by “sliding” and “hopping”.33−36 If
Lin28 were to display a similar behavior, it would increase the
likelihood of ZnK binding to the short GGAG motif for stable
complex formation. Depending on the structure and sequence
of the RNA, melting and the association of further Lin28
molecules could then occur. Such a model may also be relevant
in light of recent work showing Lin28 can also bind to DNA
and influence gene expression through the recruitment of
epigenetic modification factors.37 Future work will therefore
need to elucidate Lin28’s interaction with both the genome and
transcriptome.
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R., Coukos, G., and Zhang, L. (2010) Double-negative feedback loop
between reprogramming factor LIN28 and microRNA let-7 regulates
aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res. 70,
9463−9472.
(17) Li, N., Zhong, X., Lin, X., Guo, J., Zou, L., Tanyi, J. L., Shao, Z.,
Liang, S., Wang, L.-P., Hwang, W.-T., Katsaros, D., Montone, K., Zhao,
X., and Zhang, L. (2012) Lin-28 homologue A (LIN28A) promotes
cell cycle progression via regulation of cyclin-dependent kinase 2
(CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A
(CDC25A) expression in cancer. J. Biol. Chem. 287, 17386−17397.
(18) Hagan, J. P., Piskounova, E., and Gregory, R. I. (2009) Lin28
recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse
embryonic stem cells. Nat. Struct. Mol. Biol. 16, 1021−1025.
(19) Chang, H.-M., Triboulet, R., Thornton, J. E., and Gregory, R. I.
(2013) A role for the Perlman syndrome exonuclease Dis3l2 in the
Lin28-let-7 pathway. Nature 497, 244−248.
(20) Nam, Y., Chen, C., Gregory, R. I., Chou, J. J., and Sliz, P. (2011)
Molecular basis for interaction of let-7 microRNAs with Lin28. Cell
147, 1080−1091.
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